March 1, 2008 By:Joshua Schultz
Effective contingency planning requires implementing small but critical seeds at the outset of a study.
 |
March 1, 2008 By:Michelle Jones, Stephen Jones
In the age of international trials, data drives the selection of golden sites and investigators to get it right.
 |
 | February 1, 2008 By:Dan McDonald
Dan McDonald, vice president of business development for Excel Life Sciences, assesses the role of Site Management Organizations (SMOs) in India and discusses their contributions, which include GCP training and assistance for investigators.
 |
January 2, 2008 By:Hugh Rivers, Eric Ditkowsky
Pharma and CROs must update their infrastructures to handle the increasing use of imaging in trials.
 |
January 1, 2008 By:Kenneth A. Getz
Lack of minority clinical investigators behind dearth of minority subjects in trials.
 |
January 1, 2008 By:Beth Harper, Ann Neuer
Both parties benefit from intentional friendships, and nowadays CRAs are key to this cordial effort.
 |
January 1, 2008 By:Lee Scheible, Michael Pozsgai
Steady enrollment and optimal trial metrics can become reality with the right processes and tools.
 |
January 1, 2008 By:Ranganath Nayak, PhD
No longer a futuristic concept, adaptive clinical trials have become a reality that must be considered.
 |
|